NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

AVNR - Avanir Pharmaceuticals Inc

AVANIR Pharmaceuticals, Inc. (AVANIR), incorporated in August 1998, is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# AVNRhart

Avanir Pharmaceuticals Inc News


Avanir Pharmaceuticals CEO Presents at Bank of America Merrill Lynch Health ...
Seeking Alpha - May 17, 2012
Avanir Pharmaceuticals, Inc. (AVNR) Bank of America Merrill Lynch Health Care Conference May 17, 2012 1:00 PM ET (inaudible) one of the biotech analysts here at Bank of America Merrill Lynch.

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) No Longer Evaluates Selling Options ...
U.S. Election News - May 11, 2012
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) shares sank in last session; a day after the anemia drug maker said it is no longer plans to put itself for sale.

Canaccord Genuity Reaffirms Buy Rating on Avanir Pharmaceuticals (AVNR)
Movie News Guide (blog) - May 10, 2012
Avanir Pharmaceuticals (NASDAQ: AVNR)'s stock had its “buy” rating reaffirmed by research analysts at Canaccord Genuity in a report released on Wednesday.
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR ... - StreetInsider.com (subscription)

Avanir Pharmaceuticals' Presents at Deutsche Bank Securities Annual Health ...
Seeking Alpha - May 10, 2012
Avanir Pharmaceuticals, Inc. (AVNR) Deutsche Bank Securities Annual Health Care Conference Call May 8, 2012 2:50 PM ET Good afternoon, thanks for joining us this afternoon.

Avanir Pharmaceuticals Catches Analysts Sleeping Again
DailyFinance - May 9, 2012
By Seth Jayson, The Motley Fool Avanir Pharmaceuticals (NAS: AVNR) reported earnings on May 8. Here are the numbers you need to know.

Analysts' Ratings Reiterations for May, 9th (ADTN, AGNC, AMRN, ATEC, AVNR, BDX ...
Junction Report - May 9, 2012
American Capital Agency Corp. (NASDAQ: AGNC) had its “neutral” rating re-affirmed by analysts at Zacks. They now have a $33.00 price target on the stock.

Healthcare Stocks: Dendreon Plunges 23% (DNDN, AVNR, VVUS, GTXI, AMED, THC)
Retirement Planning - May 8, 2012
By Scott Sheffield Dendreon Corporation (NASDAQ:DNDN) slipped 23.36% to $8.96 after the Company declared first quarter result. Revenues were $82.1 million compared to $27.0 million in the prior year period.
Review:Healthcare Stocks: Dendreon Plunges 23% (DNDN, AVNR, VVUS, GTXI, AMED, THC) - The Mumbai Times

Quarterly Earnings Announcements: AAON, ADES, AER, AKRX, AMED, AMRC, APO, ARCC ...
Movie News Guide (blog) - May 8, 2012
Aaon (AAON) issued its quarterly earnings data on Tuesday. The company reported $0.18 earnings per share for the quarter, missing the analysts' consensus estimate of $0.19 by $0.01.

Avanir Pharmaceuticals Reports Fiscal 2012 Second Quarter Financial and ...
MarketWatch (press release) - May 8, 2012
ALISO VIEJO, Calif., May 8, 2012 /PRNewswire via COMTEX/ -- Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) today reported financial results for the three and six months ended March 31, 2012.
Avanir Pharmaceuticals Q2 Loss Widens - NASDAQ

Avanir Pharmaceuticals Reports Fiscal 2012 Second Quarter Financial and ...
PR Newswire (press release) - May 8, 2012
ALISO VIEJO, Calif., May 8, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today reported financial results for the three and six months ended March 31, 2012.

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>